Form 4 for MRNA Moderna
Accepted 2026-04-06 16:45:51 ET · period of report 2026-04-02 · accession 0001682852-26-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-06 16:45 | 2026-04-02 | MRNA | Mock James M | CFO | M - OptEx | — | +1,453 | 58.5K | +3% | — |
| D | 2026-04-06 16:45 | 2026-04-02 | MRNA | Mock James M | CFO | F - Tax | $50.03 | -703 | 57.7K | -1% | -$35.2K |
| D | 2026-04-06 16:45 | 2026-04-02 | MRNA | Mock James M | CFO | M - OptEx | $0.00 | -1,453 | 2,906 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-02 | M | A | 1,453 | — | 58,451 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-04-02 | F | D | 703 | $50.03 | 57,748 | D | — | — | (F2) Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2026-04-02 | M | D | 1,453 | $0.00 | 2,906 | D | — · — to — | 1,453 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. (F3) 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |